HIV-2 Protease resistance defined in yeast cells

BACKGROUND: Inhibitors of the HIV-1 Protease currently used in therapeutic protocols, have been found to inhibit, although at higher concentrations, the HIV-2 encoded enzyme homologue. Similar to observations in HIV-1 infected individuals, therapeutic failure has also been observed for some patients...

Descripción completa

Detalles Bibliográficos
Autores principales: M'Barek, Najoua Ben, Audoly, Gilles, Raoult, Didier, Gluschankof, Pablo
Formato: Texto
Lenguaje:English
Publicado: BioMed Central 2006
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570497/
https://www.ncbi.nlm.nih.gov/pubmed/16956392
http://dx.doi.org/10.1186/1742-4690-3-58

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC1570497/
https://www.ncbi.nlm.nih.gov/pubmed/16956392
http://dx.doi.org/10.1186/1742-4690-3-58

Ejemplares similares